Use of finerenone for heart failure with preserved ejection fraction carries a hyperkalemia risk, especially in patients with kidney disease.

The following is a summary of “Sodium Zirconium Cyclosilicate for Management of Hyperkalemia During Spironolactone ...

Dosage varied with the clinical situation and the degree of hyperkalemia. Whenever feasible, the resin was given orally in divided doses, totaling 20 to 60 gm. per day. The resin, a finely ground ...

This research highlights the importance of rethinking current blood pressure guidelines for diabetes patients. Lowering ...

Hyperkalemia (>5.5 mEq/L ... For congestive heart failure post-myocardial infarction, treatment is initiated at 25 mg once daily and titrated to a target of 50 mg once daily within 4 weeks.

Potassium and renal function must be routinely assessed to minimize the risk of life-threatening hyperkalemia. This review discusses the role of aldosterone antagonists in the treatment of heart ...

Reducing blood pressure could significantly reduce the risk of "major cardiovascular events" for people with type 2 diabetes, ...

The blood pressure study could help doctors treating people with diabetes to reduce the risk of "major cardiovascular events" ...

Lung cancer survival without treatment is shorter than survival with treatment. People with untreated non-small cell lung cancer—the most common type—typically live between five and 12 months after ...

People with type 2 diabetes had significantly fewer heart attacks, strokes, heart failures, and deaths from cardiovascular ...

A new study suggests that lowering blood pressure could significantly decrease the risk of "major cardiovascular events" for people with type 2 diabetes. Published in The New England Journal of ...